Cancer drug offers tantalising hope for HIV cure

Patient given nivolumab, a new generation cancer drug, shown to have a reduced reservoir of dormant HIV cells and a boosted immune response

A new generation cancer drug has raised hopes for those living with HIV after it was found to reduce the reservoir of dormant HIV cells in the body and boost the immune response of a patient.

Doctors say the effect the cancer drug nivolumab appeared to have on the patient offers a tantalising hope that it might provide a way to eradicate the virus from patients.